62 related articles for article (PubMed ID: 1281367)
1. [The dynamics of the quantitative changes in neurospecific proteins in the blood of neural cancer patients].
Fetisova IG; Chekhonin VP; Khokhlov AP; Tsydenov MM
Zh Vopr Neirokhir Im N N Burdenko; 1992; (4-5):33-5. PubMed ID: 1281367
[TBL] [Abstract][Full Text] [Related]
2. [Specific cerebral alpha 1-globulin in glial tumors].
Obukhov SK
Zh Vopr Neirokhir Im N N Burdenko; 1985; (4):43-7. PubMed ID: 2413665
[TBL] [Abstract][Full Text] [Related]
3. [Neurospecific proteins in human malignant brain tumors].
Berezin VA; Zhmarev EN; Brodskaia IA; Shevchenko GM; Zashko LS
Biull Eksp Biol Med; 1985 Jul; 100(7):68-70. PubMed ID: 2990597
[TBL] [Abstract][Full Text] [Related]
4. [Colloid osmotic pressure of the blood of patients with neurosurgical pathology].
Manevich AZ; Markin SA; Akin'shin AV; Zaletov SIu
Zh Vopr Neirokhir Im N N Burdenko; 1981; (5):18-22. PubMed ID: 7315074
[TBL] [Abstract][Full Text] [Related]
5. [Specific brain antigens as the indicators of the blood-brain barrier permeability in Alzheimer's disease].
Groppa SA; Chekhonin VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):50-2. PubMed ID: 1723824
[TBL] [Abstract][Full Text] [Related]
6. [The immunoenzyme analysis of the specific alpha2-glycoprotein in the brain in patients with neuropsychic diseases].
Chekhonin VP; Koroteeva EA; Groppa SA; Bulaeva NV; Abashidze AI; Morozov SG
Lab Delo; 1991; (8):37-42. PubMed ID: 1724505
[TBL] [Abstract][Full Text] [Related]
7. [Immunochemical study of the degradation of circulating glycoproteins and the neurospecific membrane glycoprotein D2 by cathepsin D of the human brain].
Berezin VA; Mikheev AA; Reva AD
Biokhimiia; 1984 Jul; 49(7):1138-46. PubMed ID: 6477983
[TBL] [Abstract][Full Text] [Related]
8. [Neurospecific proteins and the function of the hemato-encephalic barrier in patients with meningococcal and pneumococcal infections].
Lisukova TE; Chekhonin VP; Kashin AM; Broniakin IuV; Lidzhieva RTs; Koroteeva EA
Ter Arkh; 1991; 63(11):71-3. PubMed ID: 1725682
[No Abstract] [Full Text] [Related]
9. [Immunoenzyme method of determining brain-specific alpha 1-globulin in glial tumors].
Tatarinov IuS; Obukhov SK
Vopr Onkol; 1985; 31(1):76-9. PubMed ID: 2579508
[TBL] [Abstract][Full Text] [Related]
10. [Neurospecific proteins in the diagnosis of human brain tumors].
Berezin VA; Zhmareva EN; Romodanov SA; Shevchenko GM; Brodskaia IA
Vopr Onkol; 1985; 31(12):7-17. PubMed ID: 2417418
[No Abstract] [Full Text] [Related]
11. [An immunoenzyme analysis of the neurospecific proteins in the blood serum of epilepsy patients].
Asanova LM; Chekhonin VP; Gavrilenko AIa
Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(3):30-1. PubMed ID: 7571919
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
[TBL] [Abstract][Full Text] [Related]
13. The changes in the permeability of the blood-brain barrier when under neurosurgical intervention.
Khokhlov AP; Fetisova IG; Chekhonin VP; Malakhovsky VK
Mol Chem Neuropathol; 1993 Dec; 20(3):197-202. PubMed ID: 8172624
[TBL] [Abstract][Full Text] [Related]
14. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
15. Glial fibrillary acidic (GFA) protein immunocytochemistry in development and neuropathology.
Eng LF; DeArmond SJ
Prog Clin Biol Res; 1981; 59A():65-79. PubMed ID: 7029556
[No Abstract] [Full Text] [Related]
16. [Changes in level of serum IgG autoantibodies to nerve tissue proteins in patients with life-threatening arrhythmias].
Kliushnik TP; Danilovskaia EV; Vatolkina OE; Shkol'nikova MA; Bereznitskaia VV; Poletaev AB; Vabishchevich NK
Biull Eksp Biol Med; 1998 Jun; 125(6):677-9. PubMed ID: 9693766
[No Abstract] [Full Text] [Related]
17. [The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients].
Rudenko VA; Lisianyĭ NI; Grinevich IuA; Burkatovskaia MB; Iugrinova LG
Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):32-5. PubMed ID: 8975514
[TBL] [Abstract][Full Text] [Related]
18. [Identification, isolation and physico-chemical properties of neurospecific alpha2-globulin].
Chekhonin VP; Koroteeva EA; Morozov GV; Makarov AV
Biull Eksp Biol Med; 1991 Jan; 111(1):39-42. PubMed ID: 1711384
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of chemotherapy and immunochemotherapy in neuro-oncologic patients of various blood groups (ABO system)].
Romodanov SA; Gnedkova IA; Lisianyĭ NI; Glavatskiĭ AIa
Zh Vopr Neirokhir Im N N Burdenko; 1989; (1):17-20. PubMed ID: 2728760
[TBL] [Abstract][Full Text] [Related]
20. Structural proteins during brain development in the preterm and near-term ovine fetus and the effect of intermittent umbilical cord occlusion.
Rocha E; Totten S; Hammond R; Han V; Richardson B
Am J Obstet Gynecol; 2004 Aug; 191(2):497-506. PubMed ID: 15343227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
